# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 16, "Ann Intern Med .", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasJournal> \"Ann Intern Med .\"."
1, PublicationYear, 17, 21, "2007", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasPublicationYear> \"2007\"."
124, Title, 53, 172, "The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes : a randomized trial .", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasTitle> \"The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes : a randomized trial .\"."
2, Exenatide, 74, 83, "exenatide", "", 
3, Drug, 89, 106, "thiazolidinedione", "", 
6, Precondition, 110, 149, "suboptimally controlled type 2 diabetes", "", 
4, Type2Diabetes, 134, 149, "type 2 diabetes", "", 
5, Randomized, 154, 164, "randomized", "", 
7, Author, 173, 181, "Zinman B", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Zinman B\"."
8, Author, 190, 201, "Hoogwerf BJ", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Hoogwerf BJ\"."
9, Author, 204, 222, "Dur á n Garc í a S", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Dur á n Garc í a S\"."
10, Author, 225, 234, "Milton DR", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Milton DR\"."
11, Author, 237, 248, "Giaconia JM", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Giaconia JM\"."
12, Author, 251, 257, "Kim DD", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Kim DD\"."
13, Author, 260, 272, "Trautmann ME", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Trautmann ME\"."
14, Author, 275, 285, "Brodows RG", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasAuthor> \"Brodows RG\"."
15, Canada, 424, 430, "Canada", "", 
16, Exenatide, 667, 676, "Exenatide", "", 
17, Metformin, 718, 727, "metformin", "", 
18, Sulfonylureas, 731, 744, "sulfonylureas", "", 
19, Type2Diabetes, 758, 773, "type 2 diabetes", "", 
20, Drug, 776, 794, "Thiazolidinediones", "", 
21, Drug, 797, 801, "TZDs", "", 
23, Exenatide, 849, 858, "exenatide", "", 
22, Drug, 866, 869, "TZD", "", 
248, ObjectiveDescription, 906, 978, "To compare the effects of exenatide versus placebo on glycemic control .", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasObjectiveDescription> \"To compare the effects of exenatide versus placebo on glycemic control .\"."
24, Exenatide, 932, 941, "exenatide", "", 
25, Placebo, 949, 956, "placebo", "", 
138, Placebo, 988, 995, "Placebo", "", 
26, Randomized, 1007, 1017, "randomized", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
27, DoubleBlind, 1020, 1034, "double - blind", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
141, Placebo, 1037, 1044, "placebo", "", 
251, Duration, 1079, 1102, "May 2004 to August 2005", "", 
145, Multicenter, 1115, 1123, "49 sites", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
142, Canada, 1127, 1133, "Canada", "", "<http://ctro/data#Population_47084> <http://ctro/data#hasCountry> <http://ctro/data#Canada>."
143, Spain, 1136, 1141, "Spain", "", "<http://ctro/data#Population_47084> <http://ctro/data#hasCountry> <http://ctro/data#Spain>."
144, USA, 1152, 1165, "United States", "", "<http://ctro/data#Population_47084> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
28, NumberPatientsCT, 1179, 1182, "233", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasNumberPatientsCT> \"233\"."
31, Exenatide, 1185, 1194, "exenatide", "", 
29, NumberPatientsArm, 1207, 1210, "121", "", "<http://ctro/data#Arm_47124> <http://ctro/data#hasNumberPatientsArm> \"121\"."
32, Placebo, 1213, 1220, "placebo", "", 
30, NumberPatientsArm, 1233, 1236, "112", "", "<http://ctro/data#Arm_47133> <http://ctro/data#hasNumberPatientsArm> \"112\"."
36, Precondition, 1239, 1350, "patients with type 2 diabetes that was suboptimally controlled with TZD treatment ( with or without metformin )", "", "<http://ctro/data#Population_47084> <http://ctro/data#hasPrecondition> \"patients with type 2 diabetes that was suboptimally controlled with TZD treatment ( with or without metformin )\"."
33, Type2Diabetes, 1253, 1268, "type 2 diabetes", "", 
34, Drug, 1307, 1310, "TZD", "", 
35, Metformin, 1339, 1348, "metformin", "", 
155, Mean, 1353, 1357, "Mean", "", 
258, TimePoint, 1371, 1379, "baseline", "", 
156, HbA1c, 1380, 1403, "glycated hemoglobin A1c", "", 
38, BaseLineValue, 1414, 1419, "7 . 9", "", 
39, Percentage, 1420, 1421, "%", "", 
41, SdErrorBL, 1428, 1433, "0 . 1", "", 
40, Percentage, 1434, 1435, "%", "", 
161, SubcutaneousInjection, 1454, 1487, "Subcutaneous abdominal injections", "", "<http://ctro/data#Medication_47161> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#SubcutaneousInjection>. <http://ctro/data#Medication_47168> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#SubcutaneousInjection>."
43, DoseValue, 1491, 1493, "10", "", "<http://ctro/data#Medication_47161> <http://ctro/data#hasDoseValue> \"10\"."
44, Microgram, 1494, 1500, "microg", "", "<http://ctro/data#Medication_47161> <http://ctro/data#hasDoseUnit> <http://ctro/data#Microgram>."
45, Exenatide, 1504, 1513, "exenatide", "", "<http://ctro/data#Medication_47161> <http://ctro/data#hasDrug> <http://ctro/data#Exenatide>."
46, Placebo, 1517, 1524, "placebo", "", "<http://ctro/data#Medication_47168> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
47, Frequency, 1525, 1536, "twice daily", "", "<http://ctro/data#Intervention_47142> <http://ctro/data#hasFrequency> \"twice daily\". <http://ctro/data#Intervention_47148> <http://ctro/data#hasFrequency> \"twice daily\"."
48, Drug, 1550, 1553, "TZD", "", 
49, Metformin, 1572, 1581, "metformin", "", 
50, Duration, 1588, 1596, "16 weeks", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasCTduration> \"16 weeks\"."
253, TimePoint, 1650, 1658, "baseline", "", 
254, HbA1c, 1662, 1676, "hemoglobin A1c", "", 
171, EndPointDescription, 1705, 1732, "fasting serum glucose level", "", 
52, BodyWeight, 1735, 1746, "body weight", "", 
255, BloodGlucose, 1749, 1779, "self - monitored blood glucose", "", 
53, EndPointDescription, 1796, 1810, "adverse events", "", 
54, Exenatide, 1823, 1832, "Exenatide", "", 
256, HbA1c, 1851, 1870, "hemoglobin A ( 1c )", "", "<http://ctro/data#Endpoint_47094> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
202, Mean, 1879, 1883, "mean", "", "<http://ctro/data#Mean_47096> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_47094> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_47096>."
59, DiffGroupAbsValue, 1897, 1905, "- 0 . 98", "", "<http://ctro/data#DiffBetweenGroups_47231> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 98\"."
58, Percentage, 1906, 1907, "%", "", "<http://ctro/data#Endpoint_47094> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
55, ConfIntervalDiff, 1910, 1944, "95 % CI , - 1 . 21 % to - 0 . 74 %", "", "<http://ctro/data#DiffBetweenGroups_47231> <http://ctro/data#hasConfIntervalDiff> \"95 % CI , - 1 . 21 % to - 0 . 74 %\"."
56, Percentage, 1929, 1930, "%", "", 
57, Percentage, 1943, 1944, "%", "", 
60, FastingPlasmaGlucose, 1951, 1972, "serum fasting glucose", "", "<http://ctro/data#Endpoint_47099> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
203, Mean, 1981, 1985, "mean", "", "<http://ctro/data#Mean_47101> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_47099> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_47101>."
61, DiffGroupAbsValue, 1999, 2007, "- 1 . 69", "", 
62, Millimoles_per_litre, 2008, 2016, "mmol / L", "", "<http://ctro/data#Endpoint_47099> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre>."
67, DiffGroupAbsValue, 2019, 2027, "- 30 . 5", "", "<http://ctro/data#DiffBetweenGroups_47294> <http://ctro/data#hasDiffGroupAbsValue> \"- 30 . 5\"."
66, Mg_per_deciliter, 2028, 2035, "mg / dL", "", 
63, ConfIntervalDiff, 2040, 2107, "CI , - 2 . 22 to - 1 . 17 mmol / L { - 40 . 0 to - 21 . 1 mg / dL }", "", "<http://ctro/data#DiffBetweenGroups_47294> <http://ctro/data#hasConfIntervalDiff> \"CI , - 2 . 22 to - 1 . 17 mmol / L { - 40 . 0 to - 21 . 1 mg / dL }\"."
64, Millimoles_per_litre, 2066, 2074, "mmol / L", "", 
65, Mg_per_deciliter, 2098, 2105, "mg / dL", "", 
68, BodyWeight, 2118, 2129, "body weight", "", "<http://ctro/data#Endpoint_47104> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
204, Mean, 2132, 2136, "mean", "", "<http://ctro/data#Mean_47106> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_47104> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_47106>."
70, DiffGroupAbsValue, 2150, 2158, "- 1 . 51", "", "<http://ctro/data#DiffBetweenGroups_47357> <http://ctro/data#hasDiffGroupAbsValue> \"- 1 . 51\"."
69, Kg, 2159, 2161, "kg", "", "<http://ctro/data#Endpoint_47104> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
72, ConfIntervalDiff, 2164, 2192, "CI , - 2 . 15 to - 0 . 88 kg", "", "<http://ctro/data#DiffBetweenGroups_47357> <http://ctro/data#hasConfIntervalDiff> \"CI , - 2 . 15 to - 0 . 88 kg\"."
71, Kg, 2190, 2192, "kg", "", 
76, RelNumPatientsLeftArm, 2199, 2206, "Sixteen", "", "<http://ctro/data#Arm_47124> <http://ctro/data#hasRelNumPatientsLeftArm> \"Sixteen\"."
73, Exenatide, 2234, 2243, "exenatide", "", 
75, RelNumPatientsLeftArm, 2254, 2255, "2", "", "<http://ctro/data#Arm_47133> <http://ctro/data#hasRelNumPatientsLeftArm> \"2\"."
199, Percentage, 2256, 2257, "%", "", 
74, Placebo, 2277, 2284, "placebo", "", 
77, Exenatide, 2349, 2358, "exenatide", "", 
78, PercentageAffected, 2367, 2369, "40", "", "<http://ctro/data#Outcome_47366> <http://ctro/data#hasPercentageAffected> \"40\"."
79, NumberAffected, 2378, 2380, "48", "", "<http://ctro/data#Outcome_47366> <http://ctro/data#hasNumberAffected> \"48\"."
80, Nausea, 2407, 2413, "nausea", "", "<http://ctro/data#Endpoint_47109> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Nausea>."
81, SubGroupDescription, 2416, 2427, "mostly mild", "", "<http://ctro/data#Outcome_47393> <http://ctro/data#hasSubGroupDescription> \"mostly mild\"."
214, EndPointDescription, 2423, 2427, "mild", "", 
83, NumberAffected, 2434, 2436, "21", "", "<http://ctro/data#Outcome_47393> <http://ctro/data#hasNumberAffected> \"21\"."
215, EndPointDescription, 2442, 2450, "moderate", "", 
82, SubGroupDescription, 2442, 2450, "moderate", "", "<http://ctro/data#Outcome_47420> <http://ctro/data#hasSubGroupDescription> \"moderate\"."
84, NumberAffected, 2457, 2459, "19", "", "<http://ctro/data#Outcome_47420> <http://ctro/data#hasNumberAffected> \"19\"."
85, PercentageAffected, 2466, 2468, "13", "", "<http://ctro/data#Outcome_47447> <http://ctro/data#hasPercentageAffected> \"13\"."
86, EndPointDescription, 2483, 2491, "vomiting", "", "<http://ctro/data#EndPointDescription_47115> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_47114> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_47115>."
87, PercentageAffected, 2498, 2500, "11", "", "<http://ctro/data#Outcome_47474> <http://ctro/data#hasPercentageAffected> \"11\"."
88, Hypoglycemia, 2515, 2527, "hypoglycemia", "", "<http://ctro/data#Endpoint_47119> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia>."
89, Placebo, 2537, 2544, "placebo", "", 
90, PercentageAffected, 2553, 2555, "15", "", "<http://ctro/data#Outcome_47501> <http://ctro/data#hasPercentageAffected> \"15\"."
93, Nausea, 2582, 2588, "nausea", "", 
91, PercentageAffected, 2591, 2592, "1", "", "<http://ctro/data#Outcome_47528> <http://ctro/data#hasPercentageAffected> \"1\"."
94, EndPointDescription, 2607, 2615, "vomiting", "", 
92, PercentageAffected, 2622, 2623, "7", "", "<http://ctro/data#Outcome_47555> <http://ctro/data#hasPercentageAffected> \"7\"."
95, Hypoglycemia, 2638, 2650, "hypoglycemia", "", 
96, Drug, 2685, 2689, "TZDs", "", 
97, Sulfonylureas, 2694, 2707, "sulfonylureas", "", 
96530, RelativeFinalNumPatientsArm, 2769, 2771, "71", "", 
96531, RelativeFinalNumPatientsArm, 2778, 2780, "86", "", 
100, Exenatide, 2802, 2811, "exenatide", "", 
101, Placebo, 2816, 2823, "placebo", "", 
244, ConclusionComment, 2884, 3091, "Exenatide therapy improved glycemic control , reduced body weight , and caused gastrointestinal symptoms more than placebo in patients with type 2 diabetes that was suboptimally controlled with TZD therapy .", "", "<http://ctro/data#ClinicalTrial_47066> <http://ctro/data#hasConclusionComment> \"Exenatide therapy improved glycemic control , reduced body weight , and caused gastrointestinal symptoms more than placebo in patients with type 2 diabetes that was suboptimally controlled with TZD therapy .\"."
102, Exenatide, 2884, 2893, "Exenatide", "", 
103, BodyWeight, 2938, 2949, "body weight", "", 
104, GastrointestinalProblem, 2963, 2988, "gastrointestinal symptoms", "", 
105, Placebo, 2999, 3006, "placebo", "", 
106, Type2Diabetes, 3024, 3039, "type 2 diabetes", "", 
107, Drug, 3078, 3081, "TZD", "", 
49487, Exenatide, 3173, 3182, "exenatide", "", 
109, PMID, 3263, 3271, "17404349", "", "<http://ctro/data#Publication_47052> <http://ctro/data#hasPMID> \"17404349\"."
